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Aim
To prospectively determine treatment preferences
among parents of patients with recent onset juvenile
idiopathic arthritis participating in a randomized con-
trolled trial comparing three therapeutic strategies.
Methods
A questionnaire is taken at the start in all parents of the
participants of the BeSt for Kids trial, treated with either
initial sequential monotherapy (group 1) with either
methotrexate or sulfasalazine, initial combination ther-
apy with methotrexate and tapered prednisone (group
2), or initial combination therapy with methotrexate and
etanercept (group 3). ACRp50 is the primary goal, treat-
ment adjustments are made every 3 months to aim at
clinical remission on medication from 6 months and
onwards. The questionnaire explores parental prefer-
ences or dislikes for the initial therapy.
Results
In total, parents of 31 out of 32 so far included patients
(97%) completed the questionnaire. 38% of the parents
expressed no preference and 53% of the parents
expressed no aversion for a particular treatment group.
41% had hoped for assignment to group 3 and 6% had
hoped against assignment to group 3. Primary aversion
was highest in the second group with 25% due to dislik-
ing having to take prednisone.
Conclusions
This is the first prospective evaluation of parents’ prefer-
ences in newly diagnosed juvenile idiopathic arthritis
patients participating in the BeSt for Kids trial. Within
the limitations of the small amounts, patients clearly
preferred initial combination therapy with etanercept
and disliked taking prednisone. After actual exposure
and follow up, this questionnaire will be repeated to see
if preferences remain the same.
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